@article{ATM19734,
author = {Lihui Yin and Zijun Y. Xu-Monette and Jay Brock and Yong Li and Ken H. Young},
title = {Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations},
journal = {Annals of Translational Medicine},
volume = {6},
number = {11},
year = {2018},
keywords = {},
abstract = {Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma among adults, presenting heterogeneous biological and clinical features. The 2008 World Health Organization (WHO) classification of Epstein-Barr virus positive (EBV+) DLBCL of the elderly is limited to patients >50 years old without known immunodeficiency. The WHO classification was revised in 2016 to include immunocompetent patients of all ages and “EBV+ DLBCL of the elderly” has been replaced by “EBV+ DLBCL, not otherwise specified (EBV+ DLBCL, NOS)” (1). There are two key words differentiating EBV+ DLBCL, NOS from another lymphoma, “EBV+” and “immunocompetent”.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/19734}
}